Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tonix Pharm Holdings (NQ: TNXP )

0.1755 +0.0010 (+0.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,820,946
Open 0.1800
Bid (Size) 0.1710 (40)
Ask (Size) 0.1795 (3)
Prev. Close 0.1745
Today's Range 0.1601 - 0.1859
52wk Range 0.1202 - 1.990
Shares Outstanding 95,543,805
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
TNXP stock results show that Tonix Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
3 Biotech Stocks to Dump Before They Go to Zero
These biotech stocks to sell are burning through cash at an alarming rate and seem destined for zero, making them prime targets for selling. 
Via InvestorPlace

Performance

YTD
-58.00%
-58.00%
1 Month
+9.69%
+9.69%
3 Month
-45.50%
-45.50%
6 Month
-63.89%
-63.89%
1 Year
-90.86%
-90.86%

More News

Read More
TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Tonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What's Going On?
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain
Via ACCESSWIRE
Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of Addiction
Via ACCESSWIRE
Hope On The Horizon: Tonix Pharmaceuticals (NASDAQ:TNXP) Could Be On the Cusp of Changing Fibromyalgia Treatment Options With TNX-102 SL
Via ACCESSWIRE
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
Via InvestorPlace
New to the Street TV Series on Bloomberg and Fox Business, Innovative Companies Spotlighted: ACXP, TNXP, PETV, SWISF, GEVI, CLNV
Via AB Newswire
3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond
Via InvestorPlace
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
Via FinancialNewsMedia
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
From FN Media Group LLC
Via GlobeNewswire
Leading The Charge: Tonix Pharmaceuticals And The Future Of CNS Therapeutics
Via Get News
Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Getting Patients Addicted In Phase 3 Trial
Via Benzinga
New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval
Via ACCESSWIRE
New Hope For Fibromyalgia Patients? Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval
Via Benzinga
Exposures Product Safety
Why Tonix Pharmaceuticals (TNXP) Shares Are Plummeting
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Hope On The Horizon: Tonix Pharmaceuticals (NASDAQ: TNXP) Could Be On the Cusp of Changing Fibromyalgia Treatment Options With TNX-102 SL
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.